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Travelers can introduce viruses from disease-endem-
ic to non–disease-endemic areas. Serologic and virologic 
tests confirmed dengue virus infections in 3 travelers re-
turning to Japan: 2 from Tanzania and 1 from Côte d’Ivoire. 
Phylogenetic analysis of the envelope gene showed that 2 
genetically related virus isolates belonged to dengue virus 
type 3 genotype III.
D
engue virus (DENV) is an arthropod-borne virus that 
infects ≈100 million persons each year in Southeast 
Asia,  Central  and  South  America,  and  Africa.  Infection 
with any 1 of the 4 DENV serotypes causes a wide range 
of disease, from dengue fever to the more severe dengue 
hemorrhagic fever. Epidemics of dengue-like illness have 
occurred in Africa, but information about etiology is lim-
ited (1). Transmission of another arthropod-borne virus, 
chikungunya virus, which causes disease similar to dengue, 
has been documented in Tanzania. Although Tanzania is on 
the list of countries at risk for DENV transmission (2), to 
our knowledge, no DENV isolates have yet been identified 
and studied there.
In Japan as of June 16, 2010, a total of 50 cases of 
imported dengue had been reported. Among these cases, 2 
were dengue fever that had developed in 2 travelers after 
they returned from Tanzania. We report the molecular char-
acterization of 2 DENV type 3 (DENV-3) isolates from 1 
of the travelers who had visited Tanzania in 2010 and from 
a traveler who had visited Côte d’Ivoire in 2008.
The Study
In 2010, a 55-year-old man (patient 1) and a 23-year-old 
woman (patient 2) returned to Japan from Tanzania; high 
fever and thrombocytopenia developed in each on days 1 
and 3 days after return, respectively. In 2008, a 65-year-old 
man (patient 3) returned to Japan from Côte d’Ivoire and 
subsequently experienced high fever. Serum samples from 
each of the 3 patients were sent to the National Institute 
of Infectious Diseases, Japan, for laboratory examination. 
DENV  serotypes  were  determined  by  serotype-specific 
reverse transcription–PCR (RT-PCR) (3). DENV-specific 
immunoglobulin (Ig) M was detected by Dengue Fever Vi-
rus IgM Capture ELISA (Focus Diagnostics, Inc., Cypress, 
CA, USA) used according to the manufacturer’s instruc-
tions. Dengue IgG Indirect ELISA (Panbio Ltd, Sinnamon 
Park, Queensland, Australia) was used to detect anti-DENV 
IgG according to the manufacturer’s instructions. Serum 
from patient 1 was negative for anti-DENV IgM and anti-
DENV IgG; serum from patients 2 and 3 was positive for 
anti-DENV IgM and IgG. All 3 serum samples had positive 
DENV nonstructural protein (NS) 1 antigen results accord-
ing to NS1 capture ELISA (Platelia Dengue NS1 Antigen 
assay; Bio-Rad Laboratories, Marnes-la-Coquette, France) 
and negative chikungunya viral RNA results by RT-PCR.
DENV-3  (D3/Hu/Tanzania/NIID08/2010)  was  iso-
lated from patient 1, and DENV-3 (D3/Hu/Côte d’Ivoire/
NIID48/2008) was isolated from patient 3 by using the 
Aedes  albopictus  mosquito  cell  line  C6/36  and  FcγR-
expressing baby hamster kidney cells (4). DENV-3 RNA 
was detected in serum from patient 2 by RT-PCR, but the 
virus was not isolated. The viral RNA was extracted by us-
ing a High Pure Viral RNA Extraction kit (Roche Diagnos-
tics, Mannheim, Germany), transcribed to cDNA, ampli-
fied by PCR, and sequenced as described (3).
Nucleotide  sequences  of  the  isolates  were  compared 
with  selected  sequences  of  DENV-3  (Table).  Sequence 
alignment and phylogenetic analysis was performed by the 
Genetyx analysis program (Genetyx Corp., Tokyo, Japan). 
The phylogenetic tree was constructed by using the neighbor-
joining method. The selected DENV-3 strains were grouped 
into 5 genotypes (5). Confidence values for virus groupings 
were assessed by bootstrap assembling analysis of 1,000 rep-
licates. The 2 DENV-3 isolates belonged to DENV-3 geno-
type III (Figure). The envelope (E)-protein sequence showed 
that the DENV-3 (D3/Hu/Tanzania/NIID08/2010 strain) iso-
lated from patient 1 had a sequence homology of 98% to the 
DENV-3 D3/Hu/Côte d’Ivoire/NIID48/2008 strain and 99% 
to a DENV-3 6805 strain isolated in Saudi Arabia in 2004 
(GenBank accession no. AM746229) (6).
Conclusions
DENV transmission has occurred in western Africa 
and  some  parts  of  eastern  Africa  (7–10).  We  isolated 
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DENV-3 from 2 patients in Japan in whom dengue fever 
developed after they returned from Côte d’Ivoire (west-
ern Africa) and Tanzania (eastern Africa). Detection of 
DENV-3 in patients 1 and 2 suggests local DENV-3 trans-
mission in Tanzania. As of April 2010, at least 17 suspect-
ed cases of dengue have been reported among residents of 
Dar es Salaam, Tanzania, but the molecular epidemiology 
of DENV in Tanzania has not been analyzed (11). In the 
absence of such analyses, data on molecular epidemiology 
of DENV isolated from returning travelers offers timely 
information to countries where dengue surveillance is not 
routinely performed. Data and reports of the presence of a 
competent DENV vector, Ae. aegypti mosquitoes, suggest 
the need for further studies on local DENV transmission 
in Tanzania (12).
It is assumed that travelers increase the risk for intro-
duction of DENV serotypes or strains from disease-endem-
ic to non–disease-endemic areas where competent vectors 
such as Ae. aegypti or Ae. albopictus mosquitoes are pres-
ent. The sequence homology among the DENV-3 strain iso-
lated from the traveler to Tanzania (patient 1), the DENV-3 
strain isolated from the traveler from Côte d’Ivoire in 2008 
(patient 3), and a DENV-3 strain isolated in Saudi Arabia 
in 2004 ranged from 98% to 99% (GenBank accession nos. 
AB549332,  AB447989,  AM746229,  respectively).  Be-
cause the E-protein gene of the isolate from Tanzania was 
highly similar to those in viruses circulating regionally and 
the Middle East, the disease could have been introduced 
or reintroduced into the country from neighboring areas. 
These data suggest the need for further studies of the route 
of  disease  dissemination  and  surveillance  of  dengue  in 
Africa. Genetic differences among subtypes may result in 
differences in virus virulence and epidemic potential (13). 
DENV-3  genotype  III,  previously  isolated  from  several 
parts of Africa, Latin America, and the Indian subconti-
nent, has been associated with higher incidence of major 
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Table. Comparison of dengue virus type 3 sequences from travelers returning from Tanzania and Côte d’Ivoire with selected dengue
virus type 3 sequences* 
Year isolated Name Strain Isolate origin GenBank accession no.
2010 Tanzania2010 D3/Hu/Tanzania/NIID08/2010 Tanzania AB549332
2008 Côte d’Ivoire2008–1 D3/Hu/Côte 
d'Ivoire/NIID48/2008
Côte d’Ivoire AB447989
2008 Côte d’Ivoire2008–2 2008/00510 Côte d’Ivoire FM213456
2007 Bhutan2007–1 SV0786_07 Bhutan FJ606712
2007 Bhutan2007–2 SV0837_07 Bhutan FJ606708
2004 Saudi Arabia2004–1 6805 Saudi Arabia AM746229
2004 Saudi Arabia2004–2 6475 Saudi Arabia AM746232
2004 Colombia2004 22379_MEDELLIN/04 Colombia FJ389910
2003 India2003 GWL-25 India AY770511
2001 Venezuela2001 LARD6667 Venezuela AY146773
2000 Brazil2000 68784 Brazil AY038605
2000 Venezuela2000 LARD6315 Venezuela AY146767
2000 Cambodia–India2000† 00–28–1HuNIID Cambodia/India AB111081
1997 Thailand1997 D97–0106 Thailand AY145728
1995 Honduras1995 HN179 Honduras FJ189469
1992–1994 Malaysia1992–1994–1 LN1746 Malaysia AF147458
1992–1994 Malaysia1992–1994–2 LN2632 Malaysia AF147459
1992 Fiji1992 29472 Fiji L11422
1991 Sri Lanka1991 2783 Sri Lanka L11438
1990 Sri Lanka1990 SK698 Sri Lanka FJ189449
1989 Tahiti1989 2167 Tahiti L11619
1989 Sri Lanka1989 260698 Sri Lanka L11437
1986 Thailand1986 D86–007 Thailand L11441
1985 Mozambique1985 1559 Mozambique L11430
1984 India1984 1416 India L11424
1983 Philippines1983 168.AP-2 Philippines L11432
1981 Malaysia1981 29586 Malaysia L11427
1963 Puerto Rico1963–1 PR6 Puerto Rico L11433
1963 Puerto Rico1963–2 BS-PRico63 Puerto Rico AY146762
1956 Philippines1956 H87 Philippines L11423
2001 DENV-1 01–44–1HuNIID Tahiti AB111070
2005 DENV-2 D2/Hu/OPD030NIID/2005 East Timor AB219135
2001 DENV-4 MY01–22713 Malaysia AJ428556
*DENV, dengue virus. 
†Strain 00–28–1HuNIID was isolated from a traveler who returned to Japan after visiting Cambodia and India. epidemics of dengue and dengue hemorrhagic fever (14). 
The DENV isolates from Tanzania and Côte d’ Ivoire were 
closely related to a DENV-3 genotype III strain isolated 
from a major DENV outbreak in northern India in 2003–
2004; the E-protein gene homology was 98% (15). 
Emergence of DENV-3 genotype III in geographi-
cally diverse areas may thus result from higher epidemic 
potential of the virus, although further studies are needed 
to understand the clinical and epidemiologic implications 
of emergence or reemergence of the virus in Tanzania and 
Côte d’ Ivoire. Whereas other vector-borne diseases such 
as malaria and yellow fever have been well studied in Af-
rica, dengue needs more attention with regard to identi-
fication of epidemics, clinical implications, and disease 
management.
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Figure. Phylogenetic tree based on the envelope genome sequence 
of selected dengue virus type 3 (DENV-3) strains. The tree was 
rooted  to  DENV-1,  DENV-2  and  DENV-4.  Multiple  sequence 
alignments  were  performed,  and  the  tree  was  constructed  by 
using the neighbor-joining method. The percentage of successful 
bootstrap replication is indicated at the nodes. DENV-3 genotypes 
are indicated on the right. The isolated DENV-3 strains, D3/Hu/
Tanzania/NIID08/2010  strain  (Tanzania2010)  and  D3/Hu/Côte 
d’Ivoire/NIID48/2008 strain (Côte d’Ivoire2008), are indicated with 
arrowheads. Scale bar indicates nucleotide substitutions per site.